Filing Details
- Accession Number:
- 0001209191-23-055528
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-16 16:33:05
- Reporting Period:
- 2023-11-14
- Accepted Time:
- 2023-11-16 16:33:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1660334 | Verrica Pharmaceuticals Inc. | VRCA | Pharmaceutical Preparations (2834) | 463137900 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1741964 | Ted White | C/O Verrica Pharmaceuticals Inc. 44 West Gay Street, Suite 400 West Chester PA 19380 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-11-14 | 22,141 | $2.93 | 181,648 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-15 | 11,558 | $2.97 | 170,090 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on August 24, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $3.07 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.00 inclusive.